Gastroesophageal Reflux Disease

name: Gastroesophageal Reflux Disease
creation_date: '2025-12-18T17:01:35Z'
updated_date: '2026-02-17T21:53:14Z'
category: Complex
parents:
- Gastrointestinal Disease
disease_term:
  preferred_term: gastroesophageal reflux disease
  term:
    id: MONDO:0007186
    label: gastroesophageal reflux disease
pathophysiology:
- name: Lower Esophageal Sphincter Dysfunction
  description: >
    Transient relaxations or chronic hypotension of the LES allow
    retrograde flow of gastric contents into the esophagus. Hiatal
    hernia exacerbates sphincter incompetence.
  locations:
  - preferred_term: Lower Esophageal Sphincter
    term:
      id: UBERON:0004550
      label: gastroesophageal sphincter
  biological_processes:
  - preferred_term: Smooth Muscle Contraction
    term:
      id: GO:0006939
      label: smooth muscle contraction
  evidence:
  - reference: PMID:38177402
    supports: SUPPORT
    snippet: "GERD starts in the stomach, where the refluxate material is produced.
      Following the trajectory of reflux, the failure of the antireflux barrier, primarily
      the lower oesophageal sphincter and the crural diaphragm, enables the refluxate
      to reach the oesophageal lumen, triggering oesophageal or extra-oesophageal
      symptoms."
    explanation: This review describes the failure of the antireflux barrier,
      particularly the lower esophageal sphincter, as a core mechanism allowing
      refluxate to enter the esophagus and cause symptoms.
  - reference: PMID:38177402
    supports: PARTIAL
    snippet: "Alterations of the oesophageal mucosal integrity, such as macroscopic
      oesophagitis or microscopic changes, determine the perception of symptoms."
    explanation: Supports symptom effects of mucosal injury in GERD, but only
      indirectly supports LES dysfunction specifically.
- name: Esophageal Mucosal Injury
  description: >
    Gastric acid and pepsin damage esophageal epithelium, causing
    inflammation and erosions. Bile reflux in some patients adds
    to mucosal damage.
  locations:
  - preferred_term: Esophageal Mucosa
    term:
      id: UBERON:0002469
      label: esophagus mucosa
  cell_types:
  - preferred_term: Esophageal Epithelial Cell
    term:
      id: CL:0002252
      label: epithelial cell of esophagus
  evidence:
  - reference: PMID:38177402
    supports: SUPPORT
    snippet: "Reflux clearance mechanisms such as primary and secondary peristalsis
      and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."
    explanation: This highlights the importance of clearance mechanisms in
      preventing mucosal damage from refluxate exposure in GERD.
  - reference: PMID:38177402
    supports: SUPPORT
    snippet: "It is now recognized that different GERD phenotypes have different degrees
      of reflux, severity of mucosal integrity damage and type, and severity of symptoms."
    explanation: This review recognizes that mucosal integrity damage varies
      across GERD phenotypes and contributes to symptom severity.
- name: Impaired Esophageal Clearance
  description: >
    Reduced salivary neutralization, impaired peristalsis, and
    delayed acid clearance prolong mucosal exposure to refluxate.
  locations:
  - preferred_term: Esophagus
    term:
      id: UBERON:0001043
      label: esophagus
  biological_processes:
  - preferred_term: Digestion
    term:
      id: GO:0007586
      label: digestion
  evidence:
  - reference: PMID:38177402
    supports: SUPPORT
    snippet: "Reflux clearance mechanisms such as primary and secondary peristalsis
      and the arrival of bicarbonate-rich saliva are critical to prevent mucosal damage."
    explanation: This directly supports the role of impaired clearance
      mechanisms in prolonging refluxate exposure and increasing mucosal damage
      in GERD.
- name: Visceral Hypersensitivity
  description: >
    Some patients experience symptoms with minimal acid exposure due
    to heightened esophageal sensory perception.
  evidence:
  - reference: PMID:38177402
    supports: SUPPORT
    snippet: "The intensity of the symptoms is affected by peripheral and central
      neural and psychological mechanisms."
    explanation: This describes how neural mechanisms, including visceral
      hypersensitivity, affect symptom intensity in GERD patients even with
      varying degrees of acid exposure.
- name: Gut Microbiota Dysbiosis
  description: >
    Altered gut microbiota composition contributes to GERD risk through
    bidirectional causal relationships. Protective taxa include Actinobacteria
    and Methanobrevibacter, while risk taxa include Mollicutes and Tenericutes.
  locations:
  - preferred_term: Stomach
    term:
      id: UBERON:0000945
      label: stomach
  evidence:
  - reference: PMID:38449873
    supports: SUPPORT
    snippet: "The IVW method's findings suggested protective roles against GERD for
      the Family Clostridiales Vadin BB60 group (P = 0.027), Genus Lachnospiraceae
      UCG004 (P = 0.026), Genus Methanobrevibacter (P = 0.026), and Phylum Actinobacteria
      (P = 0.019). In contrast, Class Mollicutes (P = 0.037), Genus Anaerostipes (P
      = 0.049), and Phylum Tenericutes (P = 0.024) emerged as potential GERD risk
      factors."
    explanation: This Mendelian randomization study establishes causal
      relationships between specific gut microbiota taxa and GERD risk,
      identifying both protective and risk-associated bacterial groups.
  - reference: PMID:38449873
    supports: SUPPORT
    snippet: "For the first time, the MR analysis indicates a genetic link between
      gut microbiota abundance changes and GERD risk. This not only substantiates
      the potential of intestinal microecological therapy for GERD, but also establishes
      a basis for advanced research into the role of intestinal microbiota in the
      etiology of GERD."
    explanation: This confirms a genetic basis for the gut microbiome's causal
      role in GERD development and supports microbiome-targeted therapeutic
      approaches.
- name: Barrett's Esophagus Metaplastic Adaptation
  description: >
    Chronic reflux-induced inflammation drives metaplastic transformation of
    esophageal squamous epithelium to specialized columnar epithelium with
    altered tight junction protein expression, particularly claudin-18, which
    contributes to acid resistance.
  locations:
  - preferred_term: Esophageal Epithelium
    term:
      id: UBERON:0001976
      label: epithelium of esophagus
  evidence:
  - reference: PMID:17932229
    supports: SUPPORT
    snippet: "In SCE, Cldn-18 was the most highly expressed at the mRNA level and
      this finding is paralleled by marked elevation in protein expression on immunoblots.
      In contrast in SqE, Cldn-18 was minimally expressed at the mRNA level and undetectable
      at the protein level."
    explanation: This demonstrates that Barrett's esophagus exhibits a dramatic
      shift in tight junction protein composition, with claudin-18 becoming the
      dominant protein in metaplastic epithelium.
  - reference: PMID:17932229
    supports: SUPPORT
    snippet: "We conclude that Cldn-18 is the dominant claudin in the TJ of SCE and
      propose that the change from a Cldn-18-deficient TJ in SqE to a Cldn-18-rich
      TJ in SCE contributes to the greater acid resistance of BE."
    explanation: This establishes that the claudin-18-rich tight junctions in
      Barrett's esophagus provide enhanced acid resistance compared to normal
      squamous epithelium.
  - reference: PMID:17932229
    supports: SUPPORT
    snippet: "Barrett's esophagus (BE) is a specialized columnar epithelium (SCE)
      that develops as replacement for damaged squamous epithelium (SqE) in subjects
      with reflux disease, and as such it is apparently more acid resistant than SqE."
    explanation: This describes Barrett's esophagus as a metaplastic adaptation
      that develops in response to chronic reflux-induced damage and provides
      greater acid resistance.
phenotypes:
- name: Heartburn
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  diagnostic: true
  phenotype_term:
    preferred_term: Heartburn
    term:
      id: HP:0410281
      label: Dyspepsia
- name: Regurgitation
  category: Gastrointestinal
  frequency: VERY_FREQUENT
  phenotype_term:
    preferred_term: Regurgitation
    term:
      id: HP:0002020
      label: Gastroesophageal reflux
- name: Dysphagia
  category: Gastrointestinal
  frequency: OCCASIONAL
  notes: May indicate stricture or Barrett's
  phenotype_term:
    preferred_term: Dysphagia
    term:
      id: HP:0002015
      label: Dysphagia
- name: Chronic Cough
  category: Respiratory
  frequency: OCCASIONAL
  notes: Extraesophageal manifestation
  phenotype_term:
    preferred_term: Chronic Cough
    term:
      id: HP:0012735
      label: Cough
- name: Hoarse Voice
  category: ENT
  frequency: OCCASIONAL
  notes: Extraesophageal manifestation
  phenotype_term:
    preferred_term: Hoarse Voice
    term:
      id: HP:0001609
      label: Hoarse voice
biochemical:
- name: Esophageal pH
  presence: Abnormal
  context: Increased acid exposure time on pH monitoring
genetic:
- name: FOXF1
  association: Risk Factor
- name: MHC region
  association: Risk Factor
  notes: Associated with Barrett's esophagus
environmental:
- name: Obesity
  notes: Major modifiable risk factor
- name: Hiatal Hernia
  notes: Anatomical predisposition
- name: Smoking
  notes: Reduces LES pressure
- name: Alcohol
  notes: Relaxes LES
- name: Dietary Factors
  notes: Fatty foods, caffeine, chocolate, citrus
- name: Medications
  notes: NSAIDs, calcium channel blockers
treatments:
- name: Proton Pump Inhibitors
  description: First-line therapy (omeprazole, esomeprazole, pantoprazole).
- name: H2 Receptor Antagonists
  description: Alternative or adjunct therapy (famotidine, ranitidine).
- name: Antacids
  description: Symptomatic relief for mild symptoms.
- name: Lifestyle Modifications
  description: Weight loss, dietary changes, elevation of head of bed.
- name: Fundoplication
  description: Surgical option for refractory GERD.
- name: LINX Device
  description: Magnetic sphincter augmentation.
classifications:
  harrisons_chapter:
  - classification_value: digestive system disorder
  - classification_value: peptic disorder
datasets:
references:
- reference: DOI:10.1007/s00535-023-02065-9
  title: Mucosal neuroimmune mechanisms in gastro-oesophageal reflux disease
    (GORD) pathogenesis
  findings: []
- reference: DOI:10.1038/s41575-023-00883-z
  title: 'Pathophysiology of gastro-oesophageal reflux disease: implications for diagnosis
    and management'
  findings: []
- reference: DOI:10.1080/17474124.2023.2288156
  title: Noninvasive electrical neuromodulation for gastrointestinal motility
    disorders
  findings: []
- reference: DOI:10.1152/ajpgi.00158.2007
  title: "Claudin-18: a dominant tight junction protein in Barrett's esophagus and
    likely contributor to its acid resistance"
  findings: []
- reference: DOI:10.1186/s12967-024-05878-1
  title: Esophageal microbial dysbiosis impairs mucosal barrier integrity via
    toll-like receptor 2 pathway in patients with gastroesophageal reflux
    symptoms
  findings: []
- reference: DOI:10.3389/fimmu.2024.1327503
  title: 'Causal relationship between gut microbiota and risk of gastroesophageal
    reflux disease: a genetic correlation and bidirectional Mendelian randomization
    study'
  findings: []
- reference: DOI:10.3389/fimmu.2025.1629944
  title: 'Multidimensional mechanisms and therapies underlying gastroesophageal reflux
    disease: focus on immunity, signaling pathways, and the microbiota-gut-brain axis'
  findings: []
- reference: DOI:10.3390/biom14070877
  title: The Role and Function of TRPM8 in the Digestive System
  findings: []
- reference: DOI:10.3390/cancers16193305
  title: Mechanistic Insights on Microbiota-Mediated Development and Progression
    of Esophageal Cancer
  findings: []